[ad_1]
NEW YORK – (BUSINESS WIRE) – Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, November 2 2021. The aim of the call is to provide an update on Pfizer’s results, as reflected in the company’s third quarter 2021 performance report, which will be released that morning.
To view and listen to the webcast and view the performance report, visit our website at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors from today. Participants are advised to register prior to the conference call.
You can also listen to the conference call by dialing (833) 708-1779 within the United States and Canada or (602) 585-9859 outside the United States and Canada. The access code is “110221”.
The transcript and webcast of the call will be available on our website at www.pfizer.com/investors within 24 hours of the end of the live conference call and will be accessible for at least 90 days.
About Pfizer: Advances That Change Patients’ Lives
At Pfizer, we apply science and our global resources to provide people with therapies that significantly extend and improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health products, including innovative drugs and vaccines. Every day, Pfizer colleagues work in developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most dreaded diseases of our time. In line with our responsibility as one of the world’s leading innovative biopharmaceutical companies, we collaborate with healthcare providers, governments and local communities to support and expand access to reliable and affordable healthcare in the whole world. For more than 170 years, we’ve worked to make a difference for all those who rely on us. We regularly post information that may be important to investors on our website at www.Pfizer.com. Additionally, to find out more, visit us at www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Disclosure Notice:The webcast may include forward-looking statements regarding, among other things, our expected operational and financial performance; reorganizations; business plans and outlook; expectations for our product portfolio, in-line products and product candidates, including planned regulatory submissions, data reads, study starts, approvals, clinical trial results and other developing data that become available, contribution to revenue, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share buybacks; the plans and outlook for our acquisitions, divestitures and other business development activities, and our ability to successfully capitalize on these opportunities; manufacture and supply of products; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our experimental protease inhibitors; and our expectations regarding the impact of COVID-19 on our business, operations and financial results which are subject to substantial risks and uncertainties which could cause actual results to differ materially from those expressed or implied by these statements. A description of these risks and uncertainties can be found in Pfizer’s annual report on Form 10-K for the year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including sections thereof. entitled “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all filed with the United States Securities and Exchange Commission and available at www.sec .gov and www. pfizer.com.
Forward-looking statements made in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update any forward-looking statements contained in the webcast as a result of new information or future events or developments.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20210923005017/en/
Media:
Pamela Eisele
+1 (212) 733-1226
[email protected]
Investor:
Bryan dunn
+1 (212) 733-8917
[email protected]
Source: Pfizer Inc.
[ad_2]
Source link
